Sight Sciences (SGHT) EBIT (2020 - 2026)

Sight Sciences' EBIT history runs 7 years deep, the most recent figure standing at -$12.4 million for Q1 2026.

• In Q1 2026, EBIT rose 10.43% year-over-year to -$12.4 million; the TTM figure through Mar 2026 stood at -$6.6 million (up 86.67% YoY), while the FY2025 annual figure was -$8.1 million, up 84.04% from the prior year.
• EBIT was -$12.4 million for Q1 2026 at Sight Sciences, down from $25.4 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $25.4 million in Q4 2025 to a low of -$22.9 million in Q2 2022.
• Historically, EBIT has averaged -$12.5 million across 5 years, with a median of -$13.4 million in 2023.
• The sharpest annual moves came in 2022 and 2025: EBIT sank 106.43% in 2022, then jumped 312.62% in 2025.
• A 5-year view of EBIT shows it stood at -$17.1 million in 2022, then soared by 34.85% to -$11.1 million in 2023, then dropped by 7.37% to -$11.9 million in 2024, then jumped by 312.62% to $25.4 million in 2025, then plunged by 148.94% to -$12.4 million in 2026.
• The last three EBIT figures came in at -$12.4 million (Q1 2026), $25.4 million (Q4 2025), and -$7.9 million (Q3 2025), per Business Quant data.